Clinical Trial Update: A Proof of Concept Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS) [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept trial evaluated the safety of afamelanotide in patients with acute arterial ischemic stroke; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Ischemic Stroke

Drugs mentioned

• Afamelanotide (afamelanotide)

Snippet

Sponsor: Clinuvel Pharmaceuticals Limited | Conditions: Arterial Ischemic Stroke | Phase 2 | Status: COMPLETED | Results posted: 2023-04-11